相对于其它抗癌治疗，价格也反映了基因泰克公司对药品的感知价值。

The price also reflected Genentech's perceived value of the drug compared with other cancer treatments.

youdao

因此基因泰克公司开发了一种单克隆抗体，这种蛋白将绑定VEGF而使之失效。

So Genentech developed a monoclonal antibody, a type of protein, that would bind to VEGF and disable it.

youdao

六月份，雅培公司和基因泰克公司宣布，两公司将运用这种方法合作开发一种抗癌药。

In June, Abbott Laboratories Inc. and Genentech said they would collaborate to develop a cancer drug using this approach.

youdao